Patent ID: 7514406

Claim:
A method for treating lymphoma, comprising the step of administering to a subject in need thereof a therapeutically effective amount of a compound of Formula II: wherein R a is a member selected from the group consisting of hydrogen, C 1-6 alkyl, aryl, —OR e , —NR e R e , —CO 2 R e , —C(O)R e , —C(O)NR e R e , —CN, —NO 2 and halogen; R b is: X a is a member selected from the group consisting of O, S and NR e ; R c is a member selected from the group consisting of hydrogen, C 1-6 alkyl and aryl optionally substituted with a member selected from the group consisting of hydrogen, C 1-6 alkyl, aryl, —OR e , —NR e R e , —CN, —NO 2 and halogen; and each instance of R e is independently a member selected from the group consisting of hydrogen and C 1-6 alkyl.